SHARON RIMON: Open Payments
NPI 1801191226 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$114,252 in 380 payments from 25 companies in 2025. Trend: 2023 $84,729 · 2024 $137,149 · 2025 $114,252
Speaker / faculty: $82,799Travel & lodging: $16,208Food & beverage: $7,927Consulting: $7,318
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 81 | $38,364 |
| Lilly USA, LLC | 55 | $27,014 |
| ABBVIE INC. | 93 | $25,765 |
| PFIZER INC. | 39 | $11,198 |
| Madrigal Pharmaceuticals | 14 | $3,758 |
| EVOKE PHARMA, INC. | 7 | $3,175 |
| Phathom Pharmaceuticals, Inc. | 6 | $1,622 |
| Ferring Pharmaceuticals Inc. | 5 | $1,523 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $307 |
| Regeneron Healthcare Solutions, Inc. | 6 | $258 |
Products named: TREMFYA, VELSIPITY, OMVOH, SKYRIZI, CREON, RINVOQ, LINZESS, REZDIFFRA.
Industry payments across AZ — which companies pay providers there.
